Oxeladin citrateProduct ingredient for Oxeladin

Name
Oxeladin citrate
Drug Entry
Oxeladin

Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity.

Accession Number
DBSALT002252
Structure
Synonyms
Oxeladin hydrogen citrate